Free tool
FAERS Monitor: Descovy
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 208215 or its brand name (Descovy, Emtricitabine, Tenofovir Alafenamide Fumarate). Reports on generic versions are filed under their own applications.
Reports
11,421
Serious
8,578
75% of reports
Hospitalization
1,214
Death reported
366
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- bone density decreased4,869
- chronic kidney disease2,890
- bone loss2,649
- osteonecrosis2,620
- multiple fractures2,442
- tooth loss2,330
- osteoporosis2,283
- renal failure2,267
- pain2,017
- emotional distress1,925
- renal injury1,886
- anxiety1,786
- anhedonia1,701
- skeletal injury1,632
- osteopenia1,516
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2010 | 1 |
| 2014 | 1 |
| 2015 | 3 |
| 2016 | 59 |
| 2017 | 267 |
| 2018 | 504 |
| 2019 | 971 |
| 2020 | 4,102 |
| 2021 | 1,706 |
| 2022 | 1,242 |
| 2023 | 707 |
| 2024 | 744 |
| 2025 | 781 |
| 2026 | 333 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,042,738 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| bone lossSignal | 2,649 | 393.6 | 379.1 | 855,106 |
| skeletal injurySignal | 1,632 | 344.8 | 328.1 | 471,236 |
| bone density decreasedSignal | 4,869 | 338.6 | 330.4 | 1,386,185 |
| multiple fracturesSignal | 2,442 | 321.3 | 309.1 | 664,256 |
| tooth lossSignal | 2,330 | 233.0 | 224.1 | 478,071 |
| osteopeniaSignal | 1,516 | 204.3 | 194.3 | 276,059 |
| osteonecrosisSignal | 2,620 | 159.5 | 154.0 | 380,305 |
| anhedoniaSignal | 1,701 | 127.4 | 121.7 | 199,606 |
| renal injurySignal | 1,886 | 124.7 | 119.5 | 217,021 |
| osteoporosisSignal | 2,283 | 108.2 | 104.1 | 229,297 |
| chronic kidney diseaseSignal | 2,890 | 72.8 | 70.5 | 197,447 |
| renal failureSignal | 2,267 | 32.0 | 30.8 | 67,240 |
| emotional distressSignal | 1,925 | 29.7 | 28.5 | 52,889 |
| anxietySignal | 1,786 | 11.6 | 11.1 | 17,459 |
| painSignal | 2,017 | 6.1 | 5.8 | 8,751 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.